A20 modulates lipid metabolism and energy production to promote liver regeneration

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Damrauer, Scott M ^a,b   Studer, Peter ^a   da Silva, Cleide G ^a   Longo, Christopher R ^a   Ramsey, Haley E ^a,e   Csizmadia, Eva ^a   Shrikhande, Gautam V ^a,c   Scali, Salvatore T ^a,d   Libermann, Towia A ^a   Bhasin, Manoj K ^a   Ferran, Christiane ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CYTOCHROME C OXIDASE; EARLY GROWTH RESPONSE FACTOR 1; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OCTAMER TRANSCRIPTION FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN A20; PROTEIN CEBPA; PROTEIN P21; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; NUCLEAR PROTEIN; SIGNAL PEPTIDE; TNFAIP3 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENERGY YIELD; ENZYME ACTIVITY; FATTY ACID METABOLISM; GENE OVEREXPRESSION; GENE TARGETING; IMMUNE RESPONSE; INFLAMMATION; LIPID METABOLISM; LIVER REGENERATION; METABOLIC REGULATION; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN FUNCTION; SLC25A10 GENE; SLC25A13 GENE; VALIDATION STUDY; ANIMAL; BINDING SITE; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; GENETICS; HUMAN; LIVER; LIVER CELL; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; REPRODUCIBILITY;

ADENOVIRIDAE; MUS;

ANIMALS; BINDING SITES; CELL PROLIFERATION; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HEPATOCYTES; HUMANS; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPID METABOLISM; LIVER; LIVER REGENERATION; MICE; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; REPRODUCIBILITY OF RESULTS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 79952762862     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017715     Document Type: Article

References (72)

1. Higgins GM, Anderson RM, (1931) Experimental pathology of the liver.I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 12: 186-202.
2. Arai M, Yokosuka O, Chiba T, Imazeki F, Kato M, et al. (2003) Gene expression profiling reveals the mechanism and pathophysiology of mouse liver regeneration. J Biol Chem 278: 29813-29818.
3. Fausto N, Campbell JS, Riehle KJ, (2006) Liver regeneration. Hepatology 43: S45-53.
4. Michalopoulos GK, DeFrances MC, (1997) Liver regeneration. Science 276: 60-66.
5. Guo F, Nian H, Zhang H, Huang L, Tang Y, et al. (2006) Proteomic analysis of the transition from quiescent to proliferating stages in rat liver hepatectomy model. Proteomics 6: 3075-3086.
6. Li W, Liang X, Leu JI, Kovalovich K, Ciliberto G, et al. (2001) Global changes in interleukin-6-dependent gene expression patterns in mouse livers after partial hepatectomy. Hepatology 33: 1377-1386.
7. White P, Brestelli JE, Kaestner KH, Greenbaum LE, (2005) Identification of transcriptional networks during liver regeneration. J Biol Chem 280: 3715-3722.
8. Campbell JS, Prichard L, Schaper F, Schmitz J, Stephenson-Famy A, et al. (2001) Expression of suppressors of cytokine signaling during liver regeneration. J Clin Invest 107: 1285-1292.
9. Glantzounis GK, Salacinski HJ, Yang W, Davidson BR, Seifalian AM, (2005) The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review. Liver Transpl 11: 1031-1047.
10. Fausto N, (2000) Liver regeneration. J Hepatol 32: 19-31.
11. Longo CR, Patel VI, Shrikhande GV, Scali ST, Csizmadia E, et al. (2005) A20 protects mice from lethal radical hepatectomy by promoting hepatocyte proliferation via a p21waf1-dependent mechanism. Hepatology 42: 156-164.
12. Inderbitzin D, Beldi G, Sidler D, Studer P, Keogh A, et al. (2007) Granulocyte colony-stimulating factor supports liver regeneration in a small-for-size liver remnant mouse model. J Gastrointest Surg 11: 280-285.
13. Anderson SP, Yoon L, Richard EB, Dunn CS, Cattley RC, et al. (2002) Delayed liver regeneration in peroxisome proliferator-activated receptor-alpha-null mice. Hepatology 36: 544-554.
14. Ezaki H, Yoshida Y, Saji Y, Takemura T, Fukushima J, et al. (2009) Delayed liver regeneration after partial hepatectomy in adiponectin knockout mice. Biochem Biophys Res Commun 378: 68-72.
15. Mann DV, Lam WW, Hjelm NM, So NM, Yeung DK, et al. (2001) Human liver regeneration: hepatic energy economy is less efficient when the organ is diseased. Hepatology 34: 557-565.
16. Laherty CD, Perkins ND, Dixit VM, (1993) Human T cell leukemia virus type I Tax and phorbol 12-myristate 13-acetate induce expression of the A20 zinc finger protein by distinct mechanisms involving nuclear factor κB. J Biol Chem 268: 5032-5039.
17. Cooper JT, Stroka DM, Brostjan C, Palmetshofer A, Bach FH, et al. (1997) A20 expression inhibits endothelial cell activation. Transplant Proc 29: 881.
18. Opipari AJ, Boguski MS, Dixit VM, (1990) The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J Biol Chem 265: 14705-14708.
19. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, et al. (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430: 694-699.
20. de Jonge J, Kurian S, Shaked A, Reddy KR, Hancock W, et al. (2009) Unique early gene expression patterns in human adult-to-adult living donor liver grafts compared to deceased donor grafts. Am J Transplant 9: 758-772.
21. Arvelo MB, Cooper JT, Longo C, Daniel S, Grey ST, et al. (2002) A20 protects mice from galactosmine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology 35: 535-543.
22. Lee EG, Boone DL, Chai S, Libby SL, Chein J, et al. (2000) Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science 289: 2350-2354.
23. Ramsey HE, Da Silva CG, Longo CR, Csizmadia E, Studer P, et al. (2009) A20 protects mice from lethal liver ischemia/reperfusion injury by increasing peroxisome proliferator-activated receptor-alpha expression. Liver Transpl 15: 1613-1621.
24. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
25. Benjamini Y HY, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser 57: 289-300.
26. Inderbitzin D, Stoupis C, Sidler D, Gass M, Candinas D, (2007) Abdominal magnetic resonance imaging in small rodents using a clinical 1.5 T MR scanner. Methods 43: 46-53.
27. Klune JR, Billiar TR, Tsung A, (2008) HMGB1 preconditioning: therapeutic application for a danger signal? J Leukoc Biol 83: 558-563.
28. Coornaert B, Carpentier I, Beyaert R, (2008) A20: Central gatekeeper in inflammation and immunity. J Biol Chem.
29. Cooper JT, Stroka DM, Brostjan C, Palmetshofer A, Bach FH, et al. (1996) A20 blocks endothelial cell activation through a NF-κB-dependent mechanism. J Biol Chem 271: 18068-18073.
30. Otu HH, Naxerova K, Ho K, Can H, Nesbitt N, et al. (2007) Restoration of liver mass after injury requires proliferative and not embryonic transcriptional patterns. J Biol Chem 282: 11197-11204.
31. Skrtic S, Carlsson L, Ljungberg A, Linden D, Michalik L, et al. (2005) Decreased expression of peroxisome proliferator-activated receptor alpha and liver fatty acid binding protein after partial hepatectomy of rats and mice. Liver Int 25: 33-40.
32. Yang X, Guo M, Wan YJ, (2010) Deregulation of growth factor, circadian clock, and cell cycle signaling in regenerating hepatocyte RXRalpha-deficient mouse livers. Am J Pathol 176: 733-743.
33. Gazit V, Weymann A, Hartman E, Finck BN, Hruz PW, et al. (2010) Liver regeneration is impaired in lipodystrophic fatty liver dystrophy mice. Hepatology 52: 2109-2117.
34. Palmieri F, (2004) The mitochondrial transporter family (SLC25): physiological and pathological implications. Pflugers Arch 447: 689-709.
35. van Boxel-Dezaire AH, Stark GR, (2007) Cell type-specific signaling in response to interferon-gamma. Curr Top Microbiol Immunol 316: 119-154.
36. Zhou F, (2009) Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation. Int Rev Immunol 28: 239-260.
37. Kunter U, Daniel S, Arvelo MB, Choi J, Shukri T, et al. (2005) Combined expression of A1 and A20 achieves optimal protection of renal proximal tubular epithelial cells. Kidney Int 68: 1520-1532.
38. Dahm F, Georgiev P, Clavien PA, (2005) Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant 5: 2605-2610.
39. Shembade N, Ma A, Harhaj EW, (2010) Inhibition of NF-{kappa}B Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes. Science 327: 1135-1139.
40. Ilyin GP, Glaise D, Gilot D, Baffet G, Guguen-Guillouzo C, (2003) Regulation and role of p21 and p27 cyclin-dependent kinase inhibitors during hepatocyte differentiation and growth. Am J Physiol Gastrointest Liver Physiol 285: G115-127.
41. Sherr CJ, Roberts JM, (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149-1163.
42. Ubersax JA, Woodbury EL, Quang PN, Paraz M, Blethrow JD, et al. (2003) Targets of the cyclin-dependent kinase Cdk1. Nature 425: 859-864.
43. Garnier D, Loyer P, Ribault C, Guguen-Guillouzo C, Corlu A, (2009) Cyclin-dependent kinase 1 plays a critical role in DNA replication control during rat liver regeneration. Hepatology 50: 1946-1956.
44. Albrecht JH, Poon RY, Ahonen CL, Rieland BM, Deng C, et al. (1998) Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver. Oncogene 16: 2141-2150.
45. Shteyer E, Liao Y, Muglia LJ, Hruz PW, Rudnick DA, (2004) Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice. Hepatology 40: 1322-1332.
46. Brasaemle DL, (2006) Cell biology. A metabolic push to proliferate. Science 313: 1581-1582.
47. Farrell GC, (2004) Probing Prometheus: fat fueling the fire? Hepatology 40: 1252-1255.
48. Leclercq IA, Field J, Farrell GC, (2003) Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury. Gastroenterology 124: 1451-1464.
49. Yang SQ, Lin HZ, Mandal AK, Huang J, Diehl AM, (2001) Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology 34: 694-706.
50. Leclercq IA, Vansteenberghe M, Lebrun VB, VanHul NK, Abarca-Quinones J, et al. (2006) Defective hepatic regeneration after partial hepatectomy in leptin-deficient mice is not rescued by exogenous leptin. Lab Invest 86: 1161-1171.
51. Fernandez MA, Albor C, Ingelmo-Torres M, Nixon SJ, Ferguson C, et al. (2006) Caveolin-1 is essential for liver regeneration. Science 313: 1628-1632.
52. Mayoral R, Fernandez-Martinez A, Roy R, Bosca L, Martin-Sanz P, (2007) Dispensability and dynamics of caveolin-1 during liver regeneration and in isolated hepatic cells. Hepatology 46: 813-822.
53. Newberry EP, Kennedy SM, Xie Y, Luo J, Stanley SE, et al. (2008) Altered hepatic triglyceride content after partial hepatectomy without impaired liver regeneration in multiple murine genetic models. Hepatology 48: 1097-1105.
54. Nakatani T, Ozawa K, Asano M, Ukikusa M, Kamiyama Y, et al. (1981) Differences in predominant energy substrate in relation to the resected hepatic mass in the phase immediately after hepatectomy. J Lab Clin Med 97: 887-898.
55. Nakatani T, Yasuda K, Ozawa K, Kawashima S, Tobe T, (1982) Effects of (+)-octanoylcarnitine on deoxyribonucleic acid synthesis in regenerating rabbit liver. Clin Sci (Lond) 62: 295-297.
56. Chinetti G, Fruchart JC, Staels B, (2000) Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 49: 497-505.
57. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, et al. (1995) Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15: 3012-3022.
58. Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, et al. (1996) The PPARalpha-leukotriene B4 pathway to inflammation control. Nature 384: 39-43.
59. Roberts RA, James NH, Woodyatt NJ, Macdonald N, Tugwood JD, (1998) Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha). Carcinogenesis 19: 43-48.
60. Okaya T, Lentsch AB, (2004) Peroxisome proliferator-activated receptor-alpha regulates postischemic liver injury. Am J Physiol Gastrointest Liver Physiol 286: G606-612.
61. Mizuarai S, Miki S, Araki H, Takahashi K, Kotani H, (2005) Identification of dicarboxylate carrier Slc25a10 as malate transporter in de novo fatty acid synthesis. J Biol Chem 280: 32434-32441.
62. Saheki T, Iijima M, Li MX, Kobayashi K, Horiuchi M, et al. (2007) Citrin/mitochondrial glycerol-3-phosphate dehydrogenase double knock-out mice recapitulate features of human citrin deficiency. J Biol Chem 282: 25041-25052.
63. Haberberger TC, Kupfer K, Murphy JE, (2000) Profiling of genes which are differentially expressed in mouse liver in response to adenoviral vectors and delivered genes. Gene Ther 7: 903-909.
64. Lin R, Yang L, Nakhaei P, Sun Q, Sharif-Askari E, et al. (2006) Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20. J Biol Chem 281: 2095-2103.
65. Ferran C, Stroka DM, Badrichani AZ, Cooper JT, Wrighton CJ, et al. (1998) A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood 91: 2249-2258.
66. Nagata Y, Jones MR, Nguyen HG, McCrann DJ, St Hilaire C, et al. (2005) Vascular smooth muscle cell polyploidization involves changes in chromosome passenger proteins and an endomitotic cell cycle. Exp Cell Res 305: 277-291.
67. Banz Y, Inderbitzin D, Seiler CA, Schmid SW, Dufour JF, et al. (2007) Bridging hyperacute liver failure by ABO-incompatible auxiliary partial orthotopic liver transplantation. Transpl Int 20: 722-727.
68. Inderbitzin DT, Opitz I, Giger U, Kocher T, Krahenbuhl L, (2007) Incidence of clinical pulmonary embolism after laparoscopic surgery. Br J Surg 94: 599-603.
69. Li J, Campbell JS, Mitchell C, McMahan RS, Yu X, et al. (2009) Relationships between deficits in tissue mass and transcriptional programs after partial hepatectomy in mice. Am J Pathol 175: 947-957.
70. Stoupis C, Ludwig K, Inderbitzin D, Do DD, Triller J, (2007) Stent grafting of acute hepatic artery bleeding following pancreatic head resection. Eur Radiol 17: 401-408.
71. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
72. De Paepe B, De Bleecker JL, Van Coster R, (2009) Histochemical methods for the diagnosis of mitochondrial diseases. Curr Protoc Hum Genet Chapter 19: Unit19-12.